Beneficial Effect of Combining Radiotherapy and Transarterial Chemoembolization on Patient Survival in Hepatocellular Carcinomas and Macrovascular Invasion Treated with Sorafenib

SIMPLE SUMMARY: Systemic therapy is current standard treatment for patients with hepatocellular carcinoma (HCC) with macrovascular invasion (MaVI). However, the outcome is poor. In the present study, we analyzed the outcome of patients treated with combined sorafenib, radiotherapy (RT), and transart...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Meng-Chuan, Huang, Wen-Yen, Fan, Hsiu-Lung, Chen, Teng-Wei, Chang, Wei-Chou, Lin, Hsuan-Hwai, Shih, Yu-Lueng, Hsieh, Tsai-Yuan, Huang, Wei-Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216609/
https://www.ncbi.nlm.nih.gov/pubmed/37345023
http://dx.doi.org/10.3390/cancers15102687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216609/
https://www.ncbi.nlm.nih.gov/pubmed/37345023
http://dx.doi.org/10.3390/cancers15102687

Ejemplares similares